Abbott Laboratories (New York Stock Exchange: ABT) shares are on track for their seventh consecutive session of gains, trading up 0.4% at $119.54 on Friday.
Abbott is up 8.26% year to date, compared to the broader S&P 500, which is up 6.91%. In the last 12 months, the stock has risen 16.52%.
Looking at Search Alpha's quantitative ratings, this Illinois-based company has a Hold rating with a score of 3.27 out of 5. When it comes to Wall Street analysis, 12 out of 24 analysts recommend Strong Buy, 7 the qualify as Maintain and 5 qualify as Maintain. like a purchase.
Searching Alpha analysts have a Buy rating for the company with a score of 4 out of 5.
Abbott's fourth-quarter revenue beat estimates last month, helped by its strong medical device business. Speaking on the financials, SA Lighting Rock Research analyst said: “I anticipate they will not face as many headwinds from comparable highs in FY24, considering they have been going through such challenges over the last 4-5 quarters.”
